Teradyne, Inc. (NASDAQ: TER) announced the Iris 100, a production-ready optical test platform designed for microLED devices. The system delivers semiconductor-grade testing for next-generation optical interconnects and augmented reality displays.

Product Capabilities

The Iris 100 measures every individual emitter in an array, addressing the need for production-level precision in devices containing hundreds of thousands to millions of emitters. It integrates directly with the Teradyne UltraFLEXplus platform to enable combined optical and electrical testing.

Key technical features include:

• Spectrometer and high-resolution camera for spectral response, per-pixel luminance, and uniformity measurement
• Advanced test parallelization and image-processing algorithms for high-throughput characterization
• IG-XL software integration to detect optical defects such as dead/stuck pixels early in manufacturing
• NIST-traceable calibration workflow for absolute measurements correlating lots, wafers, and manufacturing sites

Market Context

MicroLED technology is critical for AR microdisplays and optical data interconnects in AI data center architectures. While bench-top instruments can characterize these devices in labs, they lack the throughput and cost-per-unit economics required for volume manufacturing. The Iris 100 bridges this gap by enabling per-emitter test at production throughput.

Shannon Poulin, president of the Semiconductor Test division at Teradyne, stated that microLED is shifting from lab to volume production. He noted that both AR microdisplays and optical interconnects demand per-emitter test at production throughput, which Iris 100 delivers on existing customer infrastructure.

Strategic Expansion

The Iris 100 follows the introduction of the Teradyne Photon 100 for silicon photonics and co-packaged optics test earlier this year. It also extends capabilities following the acquisition of photonic test specialist Quantifi Photonics in 2025.

Iris 100 supports wafer and final test, allowing manufacturers to add microLED test to existing fleets. A roadmap exists to support photodetector test capabilities in the same insertion.

What the Numbers Show

Teradyne’s strategy demonstrates a clear consolidation of optical test capabilities through both organic development and M&A. By integrating Iris 100 with the widely adopted UltraFLEXplus platform and IG-XL software, the company leverages existing installed bases to drive adoption of new optical test solutions without requiring customers to deploy standalone infrastructure.

Teradyne Inc. (NASDAQ: TER) shares rose 1.72% to $334.85 in Tuesday’s premarket trading, rebounding from a 13.3% drop in the previous session amid broader weakness in AI and semiconductor equipment stocks.

The gain occurred while Nasdaq futures fell 0.12% and S&P 500 futures declined 0.18%. The move signals renewed interest in higher-beta semiconductor stocks following the sharp pullback.

Technical Position

The stock trades below key short-term moving averages, indicating near-term weakness:

Despite the recent decline, the stock remains above its 200-day simple moving average, keeping the longer-term uptrend intact. The 20-day SMA remains above the 50-day SMA, and the 50-day SMA is above the 200-day SMA, both bullish longer-term signals.

Momentum has weakened, with the MACD below its signal line and a negative histogram. Key resistance sits at $379, near a cluster of short-term moving averages. Key support is at $301.50, near a recent pivot zone.

Expansion in India

Teradyne opened an office in Bengaluru on Monday to expand its presence in India’s growing semiconductor industry. The facility will support customer engagement, applications, training, and strategic partnerships.

CEO Greg Smith stated the permanent office reflects the company’s long-term commitment to India. The expansion aligns with the government’s India Semiconductor Mission, which drives investment in domestic chip manufacturing infrastructure.

Analyst Outlook

Teradyne carries a Buy consensus rating with an average price forecast of $456.09. The stock trades at a price-to-earnings ratio of about 45.2.

Recent analyst actions include:

• Baird downgraded the stock to Neutral on Aug. 21, maintaining a $420 price forecast.
• Morgan Stanley maintained an Equal-Weight rating and raised its forecast to $397 on July 30.
• Evercore ISI maintained an Outperform rating and raised its forecast to $420 on July 30.

What the Numbers Show

The divergence between Teradyne’s premium valuation and its technical position highlights current market caution. While the stock trades at a P/E of 45.2, it remains 8.9% below its 20-day SMA. This gap suggests that despite strong long-term analyst confidence (Buy consensus), near-term price action is pressured by broader sector volatility rather than company-specific fundamentals.